(225 ILCS 85/9.6) Sec. 9.6. Administration of vaccines and therapeutics by registered pharmacy technicians and student pharmacists. (a) Under the supervision of an appropriately trained pharmacist, a registered pharmacy technician or student pharmacist may administer COVID-19 and influenza vaccines subcutaneously, intramuscularly, or orally as authorized, approved, or licensed by the United States Food and Drug Administration, subject to the following conditions: (1) the vaccination must be ordered by the supervising pharmacist; (2) the supervising pharmacist must be readily and immediately available to the |
| immunizing pharmacy technician or student pharmacist;
|
|
(3) the pharmacy technician or student pharmacist must complete a practical training
|
| program that is approved by the Accreditation Council for Pharmacy Education and that includes hands-on injection technique training and training in the recognition and treatment of emergency reactions to vaccines;
|
|
(4) the pharmacy technician or student pharmacist must have a current certificate in
|
| basic cardiopulmonary resuscitation;
|
|
(5) the pharmacy technician or student pharmacist must complete, during the relevant
|
| licensing period, a minimum of 2 hours of immunization-related continuing pharmacy education that is approved by the Accreditation Council for Pharmacy Education;
|
|
(6) the supervising pharmacist must comply with all relevant recordkeeping and reporting
|
|
(7) the supervising pharmacist must be responsible for complying with requirements
|
| related to reporting adverse events;
|
|
(8) the supervising pharmacist must review the vaccine registry or other vaccination
|
| records prior to ordering the vaccination to be administered by the pharmacy technician or student pharmacist;
|
|
(9) the pharmacy technician or student pharmacist must, if the patient is 18 years of
|
| age or younger, inform the patient and the adult caregiver accompanying the patient of the importance of a well-child visit with a pediatrician or other licensed primary-care provider and must refer patients as appropriate;
|
|
(10) in the case of a COVID-19 vaccine, the vaccination must be ordered and administered
|
| according to the Advisory Committee on Immunization Practices' COVID-19 vaccine recommendations;
|
|
(11) in the case of a COVID-19 vaccine, the supervising pharmacist must comply with any
|
| applicable requirements or conditions of use as set forth in the Centers for Disease Control and Prevention COVID-19 vaccination provider agreement and any other federal requirements that apply to the administration of COVID-19 vaccines being administered; and
|
|
(12) the registered pharmacy technician or student pharmacist and the supervising
|
| pharmacist must comply with all other requirements of this Act and the rules adopted thereunder pertaining to the administration of drugs.
|
|
(b) Under the supervision of an appropriately trained pharmacist, a registered pharmacy technician or student pharmacist may administer COVID-19 therapeutics subcutaneously, intramuscularly, or orally as authorized, approved, or licensed by the United States Food and Drug Administration, subject to the following conditions:
(1) the COVID-19 therapeutic must be authorized, approved or licensed by the United
|
| States Food and Drug Administration;
|
|
(2) the COVID-19 therapeutic must be administered subcutaneously, intramuscularly, or
|
| orally in accordance with the United States Food and Drug Administration approval, authorization, or licensing;
|
|
(3) a pharmacy technician or student pharmacist practicing pursuant to this Section
|
| must complete a practical training program that is approved by the Accreditation Council for Pharmacy Education and that includes hands-on injection technique training, clinical evaluation of indications and contraindications of COVID-19 therapeutics training, training in the recognition and treatment of emergency reactions to COVID-19 therapeutics, and any additional training required in the United States Food and Drug Administration approval, authorization, or licensing;
|
|
(4) the pharmacy technician or student pharmacist must have a current certificate in
|
| basic cardiopulmonary resuscitation;
|
|
(5) the pharmacy technician or student pharmacist must comply with any applicable
|
| requirements or conditions of use that apply to the administration of COVID-19 therapeutics;
|
|
(6) the supervising pharmacist must comply with all relevant recordkeeping and reporting
|
|
(7) the supervising pharmacist must be readily and immediately available to the pharmacy
|
| technician or student pharmacist; and
|
|
(8) the registered pharmacy technician or student pharmacist and the supervising
|
| pharmacist must comply with all other requirements of this Act and the rules adopted thereunder pertaining to the administration of drugs.
|
|
(Source: P.A. 103-1, eff. 4-27-23.)
|